Kasi Healthcare, a Nigerian healthcare company, has entered a strategic partnership with Turkey’s Memorial Hospital Group to expand its presence in the $8.5 trillion global healthcare market.
The collaboration aims to enhance specialized care in Nigeria, particularly in heart treatment and organ transplants, through expertise and cutting-edge technology.
The partnership will boost the availability of second opinions and specialized medical screenings, offering Nigerian patients access to advanced evaluations and alternative care options, backed by Turkey’s world-class healthcare infrastructure.
This move is seen as a potential game-changer, reducing the need for Nigerians to seek medical treatments abroad, where billions of dollars are spent annually on outbound medical tourism.
Nigerians have spent $40 billion on healthcare and education abroad over the past decade, according to the Central Bank of Nigeria (CBN), a figure that has contributed to economic pressures, including the devaluation of the naira.
This new partnership seeks to curb those expenses by improving local healthcare offerings.
READ ALSO: Nigeria and UAE finalize bilateral aviation agreement ahead of Emirates Airlines flight resumption
Kasi Healthcare’s Aeromedical Unit will further enhance services by providing air ambulance, medical escort, and ground handling services at its Lagos airport clinic.
Visiting specialists from Memorial Hospital will offer bi-monthly consultations and second opinions, along with training programs for Nigerian healthcare providers.
Bashir Zainab Kiata, Memorial Hospital’s country executive, emphasized that the group’s network, comprising 11 hospitals, 4 medical centres, and over 1,500 doctors, including specialists and professors, is well-equipped to bring affordable and advanced healthcare to Nigeria.
She also highlighted the hospital’s success in IVF and kidney transplants and noted that this collaboration will help reduce misdiagnosis rates in Nigeria.
Kiata further stressed the importance of the partnership, especially as many Nigerians cannot afford to travel abroad for treatment.
The initiative will make specialized care more accessible, with the exception of sickle cell patients, as Nigeria lacks the facilities for post-bone marrow transplant care.
This partnership is poised to improve healthcare outcomes, reduce foreign medical expenses, and boost Nigeria’s healthcare infrastructure.
(Edited by Oludare Mayowa; omayowa@globalfinancialdigest.com; Newsroom: +234 8033 964 138)
